It has been reported that patients with germ line mutation of TCF2 develop renal tumours (Bellanne-Chantelot et al, 2004), and TCF2 mutations have been identified in renal cell cancer (Rebouissou et al, 2005). This evidence concerns the gene HNF1B and renal cell adenocarcinoma.